After a tumultuous year, a popular virtual care platform is trying its hand in a competitive blood testing market.

The telehealth platform expects the new offering to add to its user base as it draws customers looking to prevent future ...

The telehealth platform will allow customers to access testing at more than 1,000 Quest Diagnostics locations nationwide. After testing, users will receive results and consult with providers on the ...

As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

SECAUCUS, N.J., Nov. 11, 2025 /PRNewswire/ -- (NYSE: DGX), a leader in diagnostic information services, today announced that ...

Quest Diagnostics has seen its Fair Value Estimate rise moderately from $191.56 to $197.25 per share, reflecting a more optimistic outlook among analysts. This upward revision is largely due to strong ...

Quest Diagnostics Incorporated (DGX) 7th Annual Healthcare Symposium November 14, 2025 8:50 AM ESTCompany ParticipantsAsia ChangConference ...

Health is offering lab testing and sees the business as a $1B opportunity, Kelly Cloonan of Wall Street Journal reports. “You ...

The Rising Wave of Esoteric Testing The Esoteric Testing Market represents a specialized segment of diagnostic laboratory services that focuses on rare and complex tests not routinely performed in ...

Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Sam Samad, Executive Vice President and Chief Financial Officer, will speak on the company's ...

Numerous companies offer tests, which may involve blood, urine or saliva collection, and can be very expensive. The results ...

What To Know: While Quest Diagnostics raised its revenue and adjusted earnings guidance for full-year 2025, the company lowered its GAAP earnings per share guidance to a range of $8.58 to $8.66 from a ...